Viral Specific T-Lymphocytes to Treat Adenovirus, CMV and EBV
Clinical trial NCT04364178 · TERMINATED
Trial details
- NCT number
- NCT04364178
- Sponsor
- Jessie L. Alexander, MD
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-12
- Primary completion
- 2023-02-09
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.